MENU

August 2021

Distribution of Etesevimab/JS016 in the US Reopened

SHANGHAI, China, Aug. 29, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (the

Read More ➜

Settlement Notice: State Street Corporation

TO: ALL PERSONS WHO OWN SHARES OF STATE STREET CORPORATION COMMON STOCK AS OF JUNE 24, 2021 (“SHAREHOLDERS”): BOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) — Please read this notice carefully and in its entirety. Your rights may be affected by

Read More ➜

Recent News

ADVERTISMENT